SELLAS Life Sciences
SLS
SLS
30 hedge funds and large institutions have $3.7M invested in SELLAS Life Sciences in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.19% more ownership
Funds ownership: 9.71% → 10.9% (+1.2%)
18% less capital invested
Capital invested by funds: $4.51M → $3.7M (-$809K)
Holders
30
Holding in Top 10
–
Calls
$2.63M
Puts
$50K
Top Buyers
| 1 | +$869K | |
| 2 | +$198K | |
| 3 | +$117K | |
| 4 |
OCG
Opus Capital Group
Cincinnati,
Ohio
|
+$106K |
| 5 |
Bank of New York Mellon
New York
|
+$68.1K |
Top Sellers
| 1 | -$1.05M | |
| 2 | -$116K | |
| 3 | -$40.7K | |
| 4 |
Jane Street
New York
|
-$18.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.88K |